Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Laboratory Research Study of the Immunosuppressive Effect of a Cell Therapy Product on PBMC Isolated From Blood of Patients With Inflammatory Rheumatic Diseases

NCT03454932 is registered in ClinicalTrials.gov with Bone Therapeutics S.A as lead sponsor.

NCT NCT03454932
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03454932 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Laboratory Research Study of the Immunosuppressive Effect of a Cell Therapy Product on PBMC Isolated From Blood of Patients With Inflammatory Rheumatic Diseases
Lead sponsor
Bone Therapeutics S.A
Phase
Observational
Overall status
Terminated
Start date
May 31, 2015
Completion date
June 4, 2017
Enrollment
30 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

psoriatic arthritis, rheumatoid arthritis, spondylarthritis